SBIR STTR Phase I proposals adressing COVID-19
Small Business Innovation Research (SBIR) Small business Technology Transfer (STTR)- Phase I Proposals Addressing COVID-19
Subsidy: $150,000 (up to $256,000)
Deadline: project pitch required: 4 June 2020, 3 September 2020, 3 December 2020.
Full proposal upon invitation only.
Consortium: US-based small businesses can apply as single applicant or in a consortium. Additional requirements of SBIR & STTR apply
Scope: Focused on the development and deployment of new technologies, products, processes, and services with the potential to positively impact the nation’s and world’s ability to respond to the COVID-19 crisis. Areas of research that might be considered include, but are not limited to: artificial intelligence, digital health, diagnostics, distributed ledger, environmental technologies, medical devices, pharmaceutical technologies, disinfection and sterilization, and filtration and separations.
Note: when awarded a phase I grant, businesses are allowed to apply for a phase II grant (up to $1,000,000) 6-24 months after beginning phase I.
The subsidy landscape is responding quickly to the COVID-19 virus and the problems this crisis causes world-wide. A lot of new funding opportunities are being released to assist researchers and companies with their Research and Development activities against COVID-19. We have made an overview of all COVID-19 grants & funding opportunities. Check our COVID-19 Call Overview and stay up-to-date.
A more detailed and tailor-made overviews are available in 3 different products:
- Funding Scan. A summarized overview of funding opportunities for one specific R&D project with a short profile of the researcher or company. This includes a strategy with upcoming funding opportunities for the next year.
- Funding Advice. A detailed description of your company, research group, R&D projects and an overview of the timelines involved in future development. This includes a funding strategy for each project for the next 2 years.
- Funding Plan. A long-term funding strategy taking into consideration multiple R&D pillars. This detailed strategy focuses on multiple sources of funding and addresses financial weaknesses in continuing strategic planning.
Read more about it on our Strategic Funding Advice page.